story of the week
Semaglutide and Cardiovascular Outcomes in Patients With Obesity Without Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
N. Engl. J. Med 2023 Nov 11;[EPub Ahead of Print], AM Lincoff, K Brown-Frandsen, HM Colhoun, J Deanfield, SS Emerson, S Esbjerg, S Hardt-Lindberg, GK Hovingh, SE Kahn, RF Kushner, I Lingvay, TK Oral, MM Michelsen, J Plutzky, CW Tornøe, DH RyanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.